Skip to content

Chronic Kidney Disease - REAL Life Study in Alsace

Chronic Kidney Disease - REAL Life Study in Alsace

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05527626
Acronym
CKD-REAL
Enrollment
3000
Registered
2022-09-02
Start date
2022-02-17
Completion date
2027-08-01
Last updated
2023-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Diseases

Keywords

Kidney, Chronic Disease, Chronic Kidney Disease

Brief summary

Chronic kidney disease (CKD) is a public health problem and affects about 10% of the world's adult population with a constantly increasing incidence. The approach to CKD in France is centered on access to replacement therapy (dialysis, renal transplantation), the cost of which amounts to 4 billion euros (data from the REIN registry). Real-life data are essential to specify the characteristics of patients with chronic kidney disease and the factors associated with the evolution of CKD and the occurrence of complications in order to improve the management of CKD before the suppletion stage. Since October 2019, CKD at the severe stage (stage 4) and at the non-dialysis end stage (stage 5) is subject to an annual flat fee (Article L. 162-22-6-2 of the Social Security Code). The reimbursement of these lump sums by the health insurance is subject to the collection and transmission of certain medical data by the establishments.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Major subject (≥18 years) * Subject included in the MRC package (GFR \<30 ml/min/1.73 m2) * Subject who has not expressed opposition, after information, to the reuse of his or her data for the purpose of this research

Exclusion criteria

\- Subject having expressed his opposition to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Retroanalysis of the risk factors in patients with severe chronic kidney diseaseFiles analysed retrospectively from October 01, 2019 to February 31, 2027 will be examinedAnalysis of risk factors in patients with severe chronic kidney disease by retrospectively analyzing health data contained in patient medical records

Countries

France

Contacts

Primary ContactPeggy PERRIN, MD
peggy.perrin@chru-strasbourg.fr33 3 69 55 13 26
Backup ContactSaïd CHAYER, PhD, HDR
said.chayer@chru-strasbourg.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026